Maryland Hospital False Test Results Prompt Hill Inquiry; FDA, CMS Respond
This article was originally published in The Gray Sheet
Executive Summary
FDA plans to inspect Adaltis, Inc.'s Italian manufacturing facilities in "late June or early July," following a Congressional hearing May 18 related to reports of faulty test results from the firm's Labotech analyzer at a Maryland hospital